Author presents a bullish long setup for Moleculin Biotech ahead of Annamycin data readouts.
MBRX — LONG Author argues MBRX is a long setup ahead of Annamycin data readouts, citing insider buying, abnormal volume, spiking call volume, and a low $7.5M market cap as signs of pending upside. The catalyst is the imminent readout, which he expects to send the low-float stock higher. Analysts' price targets imply roughly 170% upside, and the author says risk/reward is asymmetric. He states he is long and holding for the readout.
Position: Long and holding for the readout.
This Reddit post, published January 05, 2026, features u/ZealousidealGoose193 discussing MBRX. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/ZealousidealGoose193 · Tickers: MBRX